Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis

Psoriatic arthritis (PsA) is a chronic and seronegative inflammatory arthritis occurring in patients with psoriasis. The current knowledge about the risk of malignancy associated with psoriatic arthritis (PsA) patients undergoing therapy is controversial. We focused on the relationship between malignancy and therapy and undertook a meta-analysis to address this issue.
Source: Seminars in Arthritis and Rheumatism - Category: Rheumatology Authors: Source Type: research